Bioverativ

ENJAYMO

  1. Home
  2.  / 
  3. C Code
  4.  / ENJAYMO – C9094

Manufacturer:

Bioverativ

Name:

ENJAYMO

HCPCS Code Descriptor:

Inj, sutimlimab-jome, 10 mg

Category:

C Code

HCPCS:

C9094

NDC(s):

80203-0347-01

Primary Type:

Hematology

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

ENJAYMO is a Hematology drug manufactured by Bioverativ and administered via the Intravenous route of administration. The C Code: C9094 is aligned to the drug ENJAYMO.

Access Pricing and More By Registering

HCPCS Added Date:

7/1/22

HCPCS Effective Date:

10/1/22

HCPCS Short Description:

Inj, sutimlimab-jome, 10 mg

Billing and Coding Guide:

Not Found

Patient Assistance:

Not Found

ENJAYMO - C9094